Rab11a immunohistochemical analysis does not distinguish indefinite, low-, and high-grade dysplasia in Barrett esophagus

Marie E. Robert, Mary Kay Washington, Jeffrey R. Lee, James R. Goldenring, Mary P. Bronner, John R. Goldblum, Joel K. Greenson, Marian M. Haber, John A. Hart, Laura W. Lamps, Gregory Y. Lauwers, David Lewin, Audrey J. Lazenby, Elizabeth Montgomery, James M. Crawford

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Our aim was to determine whether p53 andRablla immunoreactivity enhance diagnostic assessment of esophageal dysplasia. Histologic sections from 68 cases of Barrett esophagus obtained as part of a 12-institution study were stained with antibodies to p53 and Rab11a, randomized, and coded. The mucosal surface layer and deeper glands were scored blindly on a semiquantitative scale. The correlations between p53 and Rab11a scoring with the consensus diagnosis of dysplasia were analyzed. The histologic scale was as follows: no dysplasia, indefinite, low-grade dysplasia, high-grade dysplasia, intramucosal carcinoma, and invasive carcinoma. Rab11a staining was most prominent in epithelia negative for dysplasia but with regenerative features. There was an inverse relationship between Rab11a staining and findings of surface dysplasia (P < .02, χ2). However, statistical significance largely reflected loss of Rab11a immunoreactivity in intramucosal and invasive carcinoma, which was not a diagnostic dilemma. There was a strong positive correlation of p53 immunoreactivity with an increasing degree of epithelial dysplasia and carcinoma (P < .03, χ2). Rab11a immunoreactivity did not enhance the diagnostic assessment of dysplasia in Barrett esophagus. The previously reported positive correlation of p53 immunoreactivity with the presence of dysplasia in Barrett esophagus was confirmed.

Original languageEnglish (US)
Pages (from-to)519-527
Number of pages9
JournalAmerican Journal of Clinical Pathology
Volume124
Issue number4
DOIs
StatePublished - Oct 2005

Fingerprint

Barrett Esophagus
Carcinoma
Staining and Labeling
Epithelium
Antibodies

Keywords

  • Barrett esophagus
  • Dysplasia
  • Immunohistochemistry
  • Interobserver variation
  • Rab11a
  • p53

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Robert, M. E., Washington, M. K., Lee, J. R., Goldenring, J. R., Bronner, M. P., Goldblum, J. R., ... Crawford, J. M. (2005). Rab11a immunohistochemical analysis does not distinguish indefinite, low-, and high-grade dysplasia in Barrett esophagus. American Journal of Clinical Pathology, 124(4), 519-527. https://doi.org/10.1309/7X4GAXT15H50B48P

Rab11a immunohistochemical analysis does not distinguish indefinite, low-, and high-grade dysplasia in Barrett esophagus. / Robert, Marie E.; Washington, Mary Kay; Lee, Jeffrey R.; Goldenring, James R.; Bronner, Mary P.; Goldblum, John R.; Greenson, Joel K.; Haber, Marian M.; Hart, John A.; Lamps, Laura W.; Lauwers, Gregory Y.; Lewin, David; Lazenby, Audrey J.; Montgomery, Elizabeth; Crawford, James M.

In: American Journal of Clinical Pathology, Vol. 124, No. 4, 10.2005, p. 519-527.

Research output: Contribution to journalArticle

Robert, ME, Washington, MK, Lee, JR, Goldenring, JR, Bronner, MP, Goldblum, JR, Greenson, JK, Haber, MM, Hart, JA, Lamps, LW, Lauwers, GY, Lewin, D, Lazenby, AJ, Montgomery, E & Crawford, JM 2005, 'Rab11a immunohistochemical analysis does not distinguish indefinite, low-, and high-grade dysplasia in Barrett esophagus', American Journal of Clinical Pathology, vol. 124, no. 4, pp. 519-527. https://doi.org/10.1309/7X4GAXT15H50B48P
Robert, Marie E. ; Washington, Mary Kay ; Lee, Jeffrey R. ; Goldenring, James R. ; Bronner, Mary P. ; Goldblum, John R. ; Greenson, Joel K. ; Haber, Marian M. ; Hart, John A. ; Lamps, Laura W. ; Lauwers, Gregory Y. ; Lewin, David ; Lazenby, Audrey J. ; Montgomery, Elizabeth ; Crawford, James M. / Rab11a immunohistochemical analysis does not distinguish indefinite, low-, and high-grade dysplasia in Barrett esophagus. In: American Journal of Clinical Pathology. 2005 ; Vol. 124, No. 4. pp. 519-527.
@article{581a2c500d8145cf9f61bf0db59feefa,
title = "Rab11a immunohistochemical analysis does not distinguish indefinite, low-, and high-grade dysplasia in Barrett esophagus",
abstract = "Our aim was to determine whether p53 andRablla immunoreactivity enhance diagnostic assessment of esophageal dysplasia. Histologic sections from 68 cases of Barrett esophagus obtained as part of a 12-institution study were stained with antibodies to p53 and Rab11a, randomized, and coded. The mucosal surface layer and deeper glands were scored blindly on a semiquantitative scale. The correlations between p53 and Rab11a scoring with the consensus diagnosis of dysplasia were analyzed. The histologic scale was as follows: no dysplasia, indefinite, low-grade dysplasia, high-grade dysplasia, intramucosal carcinoma, and invasive carcinoma. Rab11a staining was most prominent in epithelia negative for dysplasia but with regenerative features. There was an inverse relationship between Rab11a staining and findings of surface dysplasia (P < .02, χ2). However, statistical significance largely reflected loss of Rab11a immunoreactivity in intramucosal and invasive carcinoma, which was not a diagnostic dilemma. There was a strong positive correlation of p53 immunoreactivity with an increasing degree of epithelial dysplasia and carcinoma (P < .03, χ2). Rab11a immunoreactivity did not enhance the diagnostic assessment of dysplasia in Barrett esophagus. The previously reported positive correlation of p53 immunoreactivity with the presence of dysplasia in Barrett esophagus was confirmed.",
keywords = "Barrett esophagus, Dysplasia, Immunohistochemistry, Interobserver variation, Rab11a, p53",
author = "Robert, {Marie E.} and Washington, {Mary Kay} and Lee, {Jeffrey R.} and Goldenring, {James R.} and Bronner, {Mary P.} and Goldblum, {John R.} and Greenson, {Joel K.} and Haber, {Marian M.} and Hart, {John A.} and Lamps, {Laura W.} and Lauwers, {Gregory Y.} and David Lewin and Lazenby, {Audrey J.} and Elizabeth Montgomery and Crawford, {James M.}",
year = "2005",
month = "10",
doi = "10.1309/7X4GAXT15H50B48P",
language = "English (US)",
volume = "124",
pages = "519--527",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "4",

}

TY - JOUR

T1 - Rab11a immunohistochemical analysis does not distinguish indefinite, low-, and high-grade dysplasia in Barrett esophagus

AU - Robert, Marie E.

AU - Washington, Mary Kay

AU - Lee, Jeffrey R.

AU - Goldenring, James R.

AU - Bronner, Mary P.

AU - Goldblum, John R.

AU - Greenson, Joel K.

AU - Haber, Marian M.

AU - Hart, John A.

AU - Lamps, Laura W.

AU - Lauwers, Gregory Y.

AU - Lewin, David

AU - Lazenby, Audrey J.

AU - Montgomery, Elizabeth

AU - Crawford, James M.

PY - 2005/10

Y1 - 2005/10

N2 - Our aim was to determine whether p53 andRablla immunoreactivity enhance diagnostic assessment of esophageal dysplasia. Histologic sections from 68 cases of Barrett esophagus obtained as part of a 12-institution study were stained with antibodies to p53 and Rab11a, randomized, and coded. The mucosal surface layer and deeper glands were scored blindly on a semiquantitative scale. The correlations between p53 and Rab11a scoring with the consensus diagnosis of dysplasia were analyzed. The histologic scale was as follows: no dysplasia, indefinite, low-grade dysplasia, high-grade dysplasia, intramucosal carcinoma, and invasive carcinoma. Rab11a staining was most prominent in epithelia negative for dysplasia but with regenerative features. There was an inverse relationship between Rab11a staining and findings of surface dysplasia (P < .02, χ2). However, statistical significance largely reflected loss of Rab11a immunoreactivity in intramucosal and invasive carcinoma, which was not a diagnostic dilemma. There was a strong positive correlation of p53 immunoreactivity with an increasing degree of epithelial dysplasia and carcinoma (P < .03, χ2). Rab11a immunoreactivity did not enhance the diagnostic assessment of dysplasia in Barrett esophagus. The previously reported positive correlation of p53 immunoreactivity with the presence of dysplasia in Barrett esophagus was confirmed.

AB - Our aim was to determine whether p53 andRablla immunoreactivity enhance diagnostic assessment of esophageal dysplasia. Histologic sections from 68 cases of Barrett esophagus obtained as part of a 12-institution study were stained with antibodies to p53 and Rab11a, randomized, and coded. The mucosal surface layer and deeper glands were scored blindly on a semiquantitative scale. The correlations between p53 and Rab11a scoring with the consensus diagnosis of dysplasia were analyzed. The histologic scale was as follows: no dysplasia, indefinite, low-grade dysplasia, high-grade dysplasia, intramucosal carcinoma, and invasive carcinoma. Rab11a staining was most prominent in epithelia negative for dysplasia but with regenerative features. There was an inverse relationship between Rab11a staining and findings of surface dysplasia (P < .02, χ2). However, statistical significance largely reflected loss of Rab11a immunoreactivity in intramucosal and invasive carcinoma, which was not a diagnostic dilemma. There was a strong positive correlation of p53 immunoreactivity with an increasing degree of epithelial dysplasia and carcinoma (P < .03, χ2). Rab11a immunoreactivity did not enhance the diagnostic assessment of dysplasia in Barrett esophagus. The previously reported positive correlation of p53 immunoreactivity with the presence of dysplasia in Barrett esophagus was confirmed.

KW - Barrett esophagus

KW - Dysplasia

KW - Immunohistochemistry

KW - Interobserver variation

KW - Rab11a

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=25844441601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25844441601&partnerID=8YFLogxK

U2 - 10.1309/7X4GAXT15H50B48P

DO - 10.1309/7X4GAXT15H50B48P

M3 - Article

C2 - 16146818

AN - SCOPUS:25844441601

VL - 124

SP - 519

EP - 527

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 4

ER -